Compound 2191
Identifiers
- Canonical SMILES:
Cc1nc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(CO)c(C)c1O
- IUPAC name:
4-{2-[5-hydroxy-3-(hydroxymethyl)-4,6-dimethylpyridin-2-yl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide
- InChi:
InChI=1S/C19H19N5O4S/c1-12-16(11-25)19(21-13(2)18(12)26)23-22-14-6-8-15(9-7-14)29(27,28)24-17-5-3-4-10-20-17/h3-10,25-26H,11H2,1-2H3,(H,20,24)
- InChiKey:
OJAXMILUMBFGAG-UHFFFAOYSA-N
External links
![]() 136226522 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 413.12 g/mol | |||
HBA | 9 | |||
HBD | 3 | |||
HBA + HBD | 12 | |||
AlogP | 3.19 | |||
TPSA | 134.33 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6606 | Sulfasalazine | DB00795 | |
0.4771 | Sulfapyridine | DB00891 | |
0.4688 | Sulfamethazine | DB01582 | |
0.4562 | Sulfamerazine | DB01581 | |
0.4524 | Sulfabromomethazine | DB11547 | |
0.4514 | Sulfaisodimidine | DB13283 | |
0.4434 | 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide | DB07056 | |
0.4151 | Sulfaperin | DB13320 | |
0.4121 | Sulfameter | DB06821 | |
0.4031 | Sulfametomidine | DB13485 | |
0.4025 | Pyridoxamine | DB11673 | |
0.4008 | Elismetrep | DB15287 | |
0.3987 | Pyridoxine | DB00165 | |
0.3949 | Sulfadiazine | DB00359 | |
0.3938 | Pyridoxal | DB00147 |